September 19, 2014
Merck Sharp & Dohme Corp. and Bristol-Myers Squibb Co. may be nearing the end of a patent row with Cipla USA Inc. over Cipla's plans to make a generic version of the antiretroviral drug Sustiva, according to a letter filed on Thursday in New Jersey federal court.
June 28, 2013
Merck Sharp & Dohme Corp. and Bristol-Myers Squibb Co. brought patent infringement allegations in New Jersey federal court Thursday against Indian generics maker Cipla USA Inc. over the company's plans to make a generic version of the HIV treatment Sustiva.